Kielbassa Andrej M, Glockner Georg, Wolgin Michael, Glockner Karl
Quintessence Int. 2016;47(10):813-823. doi: 10.3290/j.qi.a36884.
With the Minamata Convention the use of mercury will be phased down, and this undoubtedly will have an effect on dental treatment regimens and economic resources. Composite resin restorations are considered viable alternatives to amalgam fillings; however, these will not be covered completely by health insurance systems in many countries. Recently, a high-viscosity glass-ionomer cement (hvGIC) processed with a resinous coating (RC) has been introduced, and has been marketed as a restorative material in load-bearing Class I cavities (and in Class II cavities with limited size), thus serving as a possible alternative to amalgam fillings.
To evaluate the literature on this treatment approach, and to focus particularly on the clinical performance of the hvGIC/RC combination.
The Cochrane Library as well as Ebsco, Embase, PubMed, and Scopus databases were screened. Moreover, relevant abstracts published with dental meetings were reviewed.
All available randomized clinical trials focusing on the hvGIC/RC approach (published either as full-texts or abstracts until June 2016) were selected. Moreover, single-group studies using hvGIC/RC were included.
Screening of titles and abstracts, data extraction, and quality assessments of full-texts according to Oxford scoring were performed.
Regarding failure rates, minor differences between hvGIC/RC and GIC or composite resins as comparators could be observed in seven clinical studies. The hvGIC/RC combination showed high survival rates (with only few catastrophic failures) of up to 6 years.
Class I retention rates of hvGIC/RC seem promising, but further high-quality clinical studies are clearly warranted.
随着《水俣公约》的实施,汞的使用将逐步减少,这无疑会对牙科治疗方案和经济资源产生影响。复合树脂修复体被认为是汞合金填充物的可行替代品;然而,在许多国家,这些修复体并未完全纳入健康保险体系。最近,一种带有树脂涂层(RC)的高粘度玻璃离子水门汀(hvGIC)已被推出,并作为一种用于I类负重龋洞(以及尺寸有限的II类龋洞)的修复材料上市,从而成为汞合金填充物的一种可能替代品。
评估关于这种治疗方法的文献,并特别关注hvGIC/RC组合的临床性能。
对Cochrane图书馆以及Ebsco、Embase、PubMed和Scopus数据库进行了筛选。此外,还查阅了在牙科会议上发表的相关摘要。
选择了所有聚焦于hvGIC/RC方法的可用随机临床试验(截至2016年6月已发表的全文或摘要)。此外,纳入了使用hvGIC/RC的单组研究。
根据牛津评分法对标题和摘要进行筛选、数据提取以及对全文进行质量评估。
关于失败率,在七项临床研究中观察到hvGIC/RC与作为对照的玻璃离子水门汀或复合树脂之间存在细微差异。hvGIC/RC组合显示出高达6年的高生存率(仅有少数灾难性失败)。
hvGIC/RC的I类保留率似乎很有前景,但显然需要进一步开展高质量的临床研究。